Cargando…

Chronic IL-6 Administration Desensitizes IL-6 Response in Liver, Causes Hyperleptinemia and Aggravates Steatosis in Diet-Induced-Obese Mice

High-fat diet-induced obesity (DIO) is associated with fatty liver and elevated IL-6 circulating levels. IL-6 administration in rodents has yielded contradictory results regarding its effects on steatosis progression. In some models of fatty liver disease, high doses of human IL-6 ameliorate the liv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gavito, Ana Luisa, Bautista, Dolores, Suarez, Juan, Badran, Samir, Arco, Rocío, Pavón, Francisco Javier, Serrano, Antonia, Rivera, Patricia, Decara, Juan, Cuesta, Antonio Luis, Rodríguez-de-Fonseca, Fernando, Baixeras, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917096/ https://www.ncbi.nlm.nih.gov/pubmed/27333268 http://dx.doi.org/10.1371/journal.pone.0157956

Ejemplares similares

Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice
por: Vida, Margarita, et al.
Publicado: (2015)

The adiponectin promoter activator NP-1 induces high levels of circulating TNFα and weight loss in obese (fa/fa) Zucker rats
por: Decara, Juan, et al.
Publicado: (2018)

Chronic exposure to IL-6 induces a desensitized phenotype of the microglia
por: Recasens, Mireia, et al.
Publicado: (2021)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

Hyperleptinemia Is Required for the Development of Leptin Resistance
por: Knight, Zachary A., et al.
Publicado: (2010)

CB(1) Blockade Potentiates Down-Regulation of Lipogenic Gene Expression in Perirenal Adipose Tissue in High Carbohydrate Diet-Induced Obesity
por: Vida, Margarita, et al.
Publicado: (2014)

Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
por: Decara, Juan M., et al.
Publicado: (2015)

Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation
por: Sanchez-Marin, Laura, et al.
Publicado: (2017)

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
por: Rose-John, Stefan
Publicado: (2012)

Expression of IL-8, IL-6 and IL-1β in Tears as a Main Characteristic of the Immune Response in Human Microbial Keratitis
por: Santacruz, Concepcion, et al.
Publicado: (2015)

IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study
por: Sundaresh, Aparna, et al.
Publicado: (2019)

IL-6 Quotient (The Ratio of Cerebrospinal Fluid IL-6 to Serum IL-6) as a Biomarker of an Unruptured Intracranial Aneurysm
por: Kamińska, Joanna, et al.
Publicado: (2021)

Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R
por: Cupido, Arjen J., et al.
Publicado: (2022)

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6
Publicado: (1996)

Hyperleptinemia, Adiposity, and Risk of Metabolic Syndrome in Older Adults
por: Mishra, Suruchi, et al.
Publicado: (2013)

Association of hyperleptinemia with peripheral arterial disease in hypertensive patients
por: Huang, I-Ching, et al.
Publicado: (2017)

Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
por: Yoshizaki, K, et al.
Publicado: (2003)

Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
por: Wilson, Lori D, et al.
Publicado: (2012)

Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers
por: Navarro, Juan A., et al.
Publicado: (2022)

Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer
por: Liu, Chengming, et al.
Publicado: (2022)

Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4(+) T Cells
por: Rincón, Mercedes, et al.
Publicado: (1997)

Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
por: Papadopoulos, Jordan, et al.
Publicado: (2014)

Lack of IL-17 Receptor A signaling aggravates lymphoproliferation in C57BL/6 lpr mice
por: Corneth, Odilia B. J., et al.
Publicado: (2019)

IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis
por: Moon, Young-Mee, et al.
Publicado: (2012)

The IL6 Gene Promoter SNP and Plasma IL-6 in Response to Diet Intervention
por: Rana, Brinda K., et al.
Publicado: (2017)

Acetaminophen-Induced Liver Injury Alters the Acyl Ethanolamine-Based Anti-Inflammatory Signaling System in Liver
por: Rivera, Patricia, et al.
Publicado: (2017)

Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity
por: Tovar, Rubén, et al.
Publicado: (2021)

Association between hyperleptinemia and oxidative stress in obese diabetic subjects
por: Pandey, Gautam, et al.
Publicado: (2015)

Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients
por: Kuo, Chiu-Huang, et al.
Publicado: (2018)

Hyperleptinemia is associated with the aortic augmentation index in kidney transplant recipients
por: Chen, Yen-Cheng, et al.
Publicado: (2018)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer
por: Liu, Chengming, et al.
Publicado: (2022)

Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts
por: Purohit, A, et al.
Publicado: (2003)

Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
por: Flynn, Charlotte M., et al.
Publicado: (2020)

The nature of human IL-6
por: Puel, Anne, et al.
Publicado: (2019)

IL-1beta, IL-6 and IL-8 levels in gyneco-obstetric infections.
por: Basso, Beatriz, et al.
Publicado: (2005)

Circulating IL-6, IL-10, and TNF-alpha and IL-10/IL-6 and IL-10/TNF-alpha ratio profiles of polyparasitized individuals in rural and urban areas of gabon
por: M’Bondoukwé, Noé Patrick, et al.
Publicado: (2022)

IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis
por: Wang, Jianmei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1bmvpm1ppqpm8l82v897sueoce